Luligen Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial fungal infections such as dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole belongs to the azole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for targeted application to affected skin areas, ensuring high local drug concentration with minimal systemic absorption. Luligen Cream is typically applied once daily to the affected area and surrounding skin after cleansing and drying, and treatment duration varies depending on the infection type, generally ranging from 1 to 4 weeks. Common adverse effects are mild and may include local irritation, burning sensation, or erythema at the application site. Luligen Cream is contraindicated in patients with known hypersensitivity to Luliconazole or any cream excipients. Caution is advised when used in pregnant or lactating women, and the product should be kept out of reach of children. Proper adherence to prescribed treatment duration is essential to prevent recurrence and resistance development.